About Renovos
Renovos is a company based in Southampton (United Kingdom) founded in 2017 by Agnieszka Janeczek, Richard Oreffo, Jonathan Dawson, and James Otter. It operates as a HealthTech. Renovos has raised $182.91 thousand across 4 funding rounds from investors including Biocomposites, UK Research and Innovation and Henley Business Angels. Renovos offers products and services including RENOVITE®. Renovos operates in a competitive market with competitors including Kerecis, Kuros Biosciences, OssDsign, Sofregen and Cerapedics, among others.
- Headquarter Southampton, United Kingdom
- Founders Agnieszka Janeczek, Richard Oreffo, Jonathan Dawson, James Otter
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Renovos Biologics Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$182.91 K (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Biocomposites
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Renovos
Renovos offers a comprehensive portfolio of products and services, including RENOVITE®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A nanoclay platform for precise therapeutic delivery solutions.
Funding Insights of Renovos
Renovos has successfully raised a total of $182.91K across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(15 Jan 2020)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Series A - Renovos | Valuation | Henley Business Angels |
|
| Jul, 2023 | Amount | Series A - Renovos | Valuation | Biocomposites |
|
| Feb, 2022 | Amount | Grant - Renovos | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Renovos
Renovos has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Biocomposites, UK Research and Innovation and Henley Business Angels. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A network of investors and entrepreneurs is facilitated by Henley Business Angels.
|
Founded Year | Domain | Location | |
|
Synthetic calcium composites are developed for bone repair and regeneration.
|
Founded Year | Domain | Location | |
|
Research and innovation funding is managed for UK advancement.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Renovos
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Renovos
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Renovos Comparisons
Competitors of Renovos
Renovos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, Kuros Biosciences, OssDsign, Sofregen and Cerapedics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| domain | founded_year | HQ Location |
Provider of smart solutions for bone disease management
|
|
| domain | founded_year | HQ Location |
Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma
|
|
| domain | founded_year | HQ Location |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| domain | founded_year | HQ Location |
Osteobiologic products are developed using synthetic peptide technology.
|
|
| domain | founded_year | HQ Location |
Developer of treatments for cartilage and bone problems
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Renovos
Frequently Asked Questions about Renovos
When was Renovos founded?
Renovos was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Renovos located?
Renovos is headquartered in Southampton, United Kingdom.
Is Renovos a funded company?
Renovos is a funded company, having raised a total of $182.91K across 4 funding rounds to date. The company's 1st funding round was a Grant of $784.16K, raised on Jan 15, 2020.
What does Renovos do?
Renovos is engaged in developing advanced regenerative medicine solutions through its proprietary RENOVITE nanoclay technology platform. This platform is utilized as an injectable scaffold to host regenerative cells and template new tissue formation. It is designed to localize and retain biologics for safer and more efficient applications at reduced doses. The company addresses unmet clinical needs in tissue regeneration, targeting age-related diseases and trauma in both aging and active populations. Solutions are aimed at providing economic benefits to health systems and improved outcomes for patients to support active living and healthy aging.
Who are the top competitors of Renovos?
Renovos's top competitors include Kerecis, BONESUPPORT and OssDsign.
What products or services does Renovos offer?
Renovos offers RENOVITE®.
Who are Renovos's investors?
Renovos has 4 investors. Key investors include Biocomposites, UK Research and Innovation, Henley Business Angels, and Orthopaedic Research UK.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.